A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV

Biomedical Chromatography

Volumn 18, Issue 5, 2004, Pages 282-287

  Rudek, Michelle A ^a   Zabelina, Yelena ^a   Zhao, Ming ^a   Wolff, Antonio C ^a   Baker, Sharyn D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Dimethyl benzoylphenyl urea (BPU; LC UV; Pharmacokinetics

Indexed keywords

ACETONITRILE; CHLORINE COMPOUNDS; METABOLISM; PHARMACOKINETICS; TUMORS;

DIMETHYL BENZOYLPHENYL UREA (BENZOYLPHENYL UREA; HUMAN PLASMAS; IN-PHASE; IN-VITRO; LC/UV; MICROTUBULES; PACLITAXEL; PLASMA CONCENTRATION; SOLID TUMORS; TUBULIN POLYMERIZATION;

UREA;

ACETONITRILE; CARBANILAMIDE DERIVATIVE; DIMETHYLBENZOYLPHENYLUREA; NSC 639829; PACLITAXEL; TUBULIN; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG BLOOD LEVEL; DRUG MECHANISM; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MICROTUBULE; PHARMACODYNAMICS; PROTEIN POLYMERIZATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SOLID TUMOR; ULTRAVIOLET RADIATION;

EID: 4243187156     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.314     Document Type: Article

References (7)

1. Edelman MJ, Bauer KS, Meiller T et al. Phase I, pharmacokinetic (PK) and pharmacodynamic study of benzoylphenylurea (BPU, NSC 639829), a novel antitubulin agent. Proceedings of the American Society of Clinical Oncology 2003, 22: 137.
2. Food and Drug Administration Center, US Department of Health and Human Services. Guidance for industry bioanalytical method validation, May 2001.
3. Hollingshead MG, Sackett DL, Alley MC et al. The anticancer activity of six benzoylphenylurea compounds and their interaction with tubulin. Proceedings of the American Association of Cancer Research 1998; 39: 164a.
4. Jain N, Yang G, Tabibi SE et al. Solubilization of NSC-639829. International Journal of Pharmacy 2001; 225: 41-47.
5. Messersmith WA, Baker SD, Donehower RC et al. Phase I study of continuous weekly dosing of dimethyl benzoylphenylurea (BPU) in patients with solid tumors. Proceedings of the American Society of Clinical Oncology 2003: 22: 203.
6. Okada H, Kato M, Koyanagi T et al. Synthesis and antitumor activities of water-soluble benzoylphenylureas. Chemical and Pharmaceutical Bulletin (Tokyo) 1999: 47: 430-433.
7. Zhao M, Zabelina Y, Rudek MA et al. A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis xxx 2003; 1-9 (in press).